top of page

Science & Innovation 

ASCO's 14th Annual Report on Progress Against Cancer 

Clinical Cancer Advances highlights the most impactful research advances of the past year and identifies cancer research priorities to accelerate progress against cancer.

Video of 2018-2019 ASCO president Dr. Monica M. Bertagnolli delivering her Presidential Address at the Opening Session of 2019 ASCO Annual Meeting on Saturday, June 1, 2019.

How a New Cancer 'Vaccine' Fights Tumors Throughout the Body 

By Rachael Rettner, Senior Writer | April 8, 2019 01:48pm ET | LiveScience Health

A new cancer “vaccine” that’s injected directly into a single tumor can trigger the immune system to attack cancer cells throughout the body, a small new study suggests.

NICE Approves CAR-therapy Kymriah to Diffuse Large B-cell Lymphoma in Adults

February 1, 2019 | Oncology Central

The National Institute for Health and Care Excellence (NICE) has approved Novartis’ CAR-T therapy Kymriah® (tisagenlecleucel) for the treatment of diffuse large B-cell lymphoma in adults, following a commercial agreement with NHS England.

Milestones in Modern Oncology: How Far Have We Come?

January 26, 2019 | Oncology Central

Cancer advancements 2018–2019

During 2018 immuno-oncology once again was an immensely popular hot topic. At both the American Association for Cancer Research Annual Meeting 2018 (AACR, April 14–18, IL, USA) and the American Society of Clinical Oncology Annual Meeting (ASCO, 1–5 June 2018, IL, USA) several key studies were presented, which highlighted high success rates with novel immuno-oncology combinations.

What Cancer Patients Should Know: Latest Immunotherapy News from ASCO 2018

Panelists include Charles G. Drake, M.D., Ph.D., of New York-Presbyterian/Columbia University Medical Center, and Catherine Diefenbach, M.D., and Jeffrey S. Weber, M.D., of the Perlmutter Cancer Center at NYU Langone Health. Jill O’Donnell-Tormey, Ph.D., of the Cancer Research Institute, moderates.

Immunotherapy experts discuss the latest cancer immunotherapy advances featured the 2018 annual meeting of the American Society of Clinical Oncology (ASCO).

 

Topics

– combination immunotherapy
– biomarker development
– CAR T cell therapies
– new approaches to immune-based cancer treatment.

Video and information source: Cancer Resource Institute

Harnessing the Immune System to Fight Cancer

New York Time Article July 30, 2016New drugs and methods of altering a patient’s own immune cells are helping some cancer patients – but not all – even when standard treatments fail.

bottom of page